Fintel reports that on October 20, 2025, JP Morgan upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underweight to Neutral. Analyst Price Forecast Suggests 18.55% Downside As of ...
Think your WAF has you covered? Think again. This holiday season, unmonitored JavaScript is a critical oversight allowing attackers to steal payment data while your WAF and intrusion detection systems ...
On July 22, 2025, Replimune publicly announced that the U.S. Food and Drug Administration (FDA) had issued a "Complete Response Letter" (CRL) for its Biologics License Application (BLA) for RP1. This ...
The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...
On July 22, 2025, Replimune revealed that the FDA had issued a Complete Response Letter (CRL) for its Biologics License Application for RP1, a novel immunotherapy aimed at treating advanced melanoma.
The breach hit core JavaScript libraries such as chalk and strip-ansi, downloaded billions of times each week, raising alarms over the security of open-source software. Hackers have compromised widely ...
Though it's been over 27 years since the movie Titanic came out, for one woman, it feels like yesterday. Sarah Boll loves Titanic, telling PEOPLE she's seen the film "over 500 times," having initially ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果